Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function.

Aarti Sharma | Alexander K Lyashchenko | Lei Lu | Sara Ebrahimi Nasrabady | Margot Elmaleh | Monica Mendelsohn | Adriana Nemes | Juan Carlos Tapia | George Z Mentis | Neil A Shneider
Nature communications | 2016

Mutations in FUS cause amyotrophic lateral sclerosis (ALS), including some of the most aggressive, juvenile-onset forms of the disease. FUS loss-of-function and toxic gain-of-function mechanisms have been proposed to explain how mutant FUS leads to motor neuron degeneration, but neither has been firmly established in the pathogenesis of ALS. Here we characterize a series of transgenic FUS mouse lines that manifest progressive, mutant-dependent motor neuron degeneration preceded by early, structural and functional abnormalities at the neuromuscular junction. A novel, conditional FUS knockout mutant reveals that postnatal elimination of FUS has no effect on motor neuron survival or function. Moreover, endogenous FUS does not contribute to the onset of the ALS phenotype induced by mutant FUS. These findings demonstrate that FUS-dependent motor degeneration is not due to loss of FUS function, but to the gain of toxic properties conferred by ALS mutations.

Pubmed ID: 26842965

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: T32 NS064928
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS07377
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007367
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS078375
  • Agency: NINDS NIH HHS, United States
    Id: T32 NS064928-06
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK057521
  • Agency: NINDS NIH HHS, United States
    Id: NS078375

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


International Mouse Phenotyping Consortium (IMPC) (tool)

RRID:SCR_006158

Center that produces knockout mice and carries out high-throughput phenotyping of each line in order to determine function of every gene in mouse genome. These mice will be preserved in repositories and made available to scientific community representing valuable resource for basic scientific research as well as generating new models for human diseases.

View all literature mentions